Veracyte, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 4.84

Veracyte, Inc. Current Ratio is 4.84 for the Trailing 12 Months (TTM) ending March 31, 2025, a 2.56% change year over year. Current ratio represents the short-term liquidity measurement, showing current assets' coverage of liabilities. Higher ratio implies better ability to meet short-term obligations.
  • Veracyte, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 4.72, a 14.43% change year over year.
  • Veracyte, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 4.12, a -18.96% change year over year.
  • Veracyte, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 5.08, a -69.62% change year over year.
  • Veracyte, Inc. Current Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 16.74, a 40.86% change year over year.
Key Data
Date Current Ratio Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE)